BSE filing, NSE: WIPRO. Summary written from the filing by ALFA Finder's alert engine.
Wipro Ltd: key numbers
- Share price
- ₹184.50
- Market cap
- ₹1,82,755 Cr
- Revenue (annual)
- ₹92,624 Cr
- Net profit (annual)
- ₹13,197 Cr
- P/E (TTM)
- 13.9×Sector 22.9×
- Promoter holding
- 72.58%-0.01% QoQ
- FII holding
- 9.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wipro Ltd
All →Wipro Other Announcement
Wipro designated person Anubhav Pateriya acquired 94,466 ADRs via RSU/PSU exercise on October 27, 2026. This PIT Reg 7(2) filing discloses the ADR acquisition.
Wipro Earnings Call Transcript: Key Takeaways
Wipro reported flat sequential revenue of $2.61B for Q2 FY27 with margins expanding to 16.5%. Strategy centers on AI-powered consulting and sector-specific transformations.
Wipro Results Update
Wipro reported Q2 FY27 gross revenue of $2,583 million and net income of $333.9 million. Operating margin expanded 0.5% QoQ to 16.5% with EPS up 4.2% YoY.
Wipro Q2 FY27 Results: Net Profit ₹3,200 Cr, Down 1.9% YoY
Wipro Ltd reported revenue from operations of ₹24,753 Cr (+9.1% YoY) and net profit of ₹3,200 Cr (-1.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹3,200 Cr · -1.9% YoY
Wipro Price Movement Clarification
Wipro clarified that the recent U.S. PERM application suspension will not have a material business impact. The company emphasized its existing U.S. localization strategy.
Wipro Employee Stock Options
Wipro granted 2,46,048 Restricted Stock Units to identified employees under its 2024 scheme, effective October 12, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date